Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) fundamentals
Biofil Chemicals & Pharmaceuticals Limited is a listed company in Pharmaceuticals & Biotechnology, part of the Healthcare sector, listed on the NSE as BIOFILCHEM (ISIN INE829A01014). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Biofil Chemicals & Pharmaceuticals Limited does
Biofil Chemicals and Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing and trading pharmaceutical products. The Company operates through two segments: the Pharmaceutical Division and the Chemicals Division. It is also involved in the business activity of producing plastic products, which are used for the purpose of packing pharmaceutical product and other plastic products. The Company’s product categories include Basic Drugs & Chemicals, and Plastic Dripper & Caps. Its Basic Drugs & Chemicals include Sodium Chloride, Potassium Chloride, Sodium Citrate, Diethyl Carbamazine Citrate, Ferrous Sulphate, Dried Ferrous Sulphate, Ferrus Fumerate, Micro Crystalline Cellulose and Dicyclomine Hydrochloride. The Company's plants are located at Kheda Industrial Estate, Pithampur District, Dhar, and Sanwer Road, Industrial Area, Indore in Madhya Pradesh. The Company also deals in providing job work facilities in respect of the manufacturing of pharmaceutical drugs.
Valuation and market data
| Last close | ₹34.51 |
|---|---|
| Market capitalisation | ₹56 crore |
| Enterprise value | ₹54 crore |
| P/E (TTM) | 20.18 |
| Price to book | 2.61 |
| Price to sales (TTM) | 1.02 |
| Book value per share | ₹13.21 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Listed since | Wed Jun 12 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹31 crore | ₹3 crore | ₹3 crore | 1.71 |
| Mar 2025 | ₹34 crore | ₹1 crore | ₹1 crore | 0.34 |
| Mar 2024 | ₹41 crore | ₹1 crore | ₹1 crore | 0.44 |
| Mar 2023 | ₹30 crore | ₹1 crore | ₹1 crore | 0.34 |
| Mar 2022 | ₹23 crore | ₹1 crore | ₹1 crore | 0.44 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 46.8% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.1% |
| Retail and others | 53.1% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.